Overview

This presentation will highlight the role of albuminuria as a sign of vascular damage in the cardiorenal system and as a strong, independent predictor of cardiovascular risk. It will equip attendees with practical strategies and guideline recommendations for implementing UACR testing to proactively identify CKD and manage hidden cardiovascular risk in patients. 

SPONSORED BY

Boehringer Ingelheim Pharmaceuticals, Inc.